Command Palette

Search for a command to run...

ACUTAAS

1483.7+0.86%
Market Cap
₹11,570.53 Cr
Stock P/E
72.52
ROCE
20.14%
ROE
16.19%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Institution
Public
Others

Financials

YoY Net Sales
EPS Growth
Operating Margin

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Laggard

Acutaas Chemicals Ltd. shows promising revenue growth but struggles with high valuation metrics compared to peers. The company is outperformed by several competitors in profitability and efficiency metrics, positioning it as a sector laggard despite its growth potential.

Key Points
  • Acutaas Chemicals Ltd. has a high revenue growth rate but a high PE ratio, indicating overvaluation.
  • Cipla Ltd. stands out as a value pick due to its low PE and high profitability.
  • Divi's Laboratories Ltd. shows concerning growth patterns despite high margins.
Top Performers
Cipla Ltd.

Lowest PE at 23.73 and strong ROE of 16.63, marking it as a value pick with attractive profitability.

Dr. Reddy's Laboratories Ltd.

Strong profitability metrics with a PE of 15.50 and high ROE of 21.76, making it a strong overall performer.